Rakovina Therapeutics Inc (RKV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 822 | 1,883 | 76 | 1,313 | 255 |
| Receivables | 153 | 117 | 59 | 81 | 142 |
| TOTAL | $1,691 | $2,842 | $933 | $2,263 | $1,196 |
| Non-Current Assets | |||||
| Intangibles | 3,576 | 3,712 | 3,845 | 3,977 | 4,113 |
| TOTAL | $3,576 | $3,712 | $3,845 | $3,977 | $4,113 |
| Total Assets | $5,268 | $6,554 | $4,778 | $6,241 | $5,308 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,437 | 1,412 | 1,387 | 1,419 | N/A |
| Accounts payable and accrued liabilities | 684 | 759 | 871 | 421 | 708 |
| Accrued Expenses | 59 | 26 | N/A | N/A | N/A |
| TOTAL | $2,180 | $2,220 | $2,386 | $1,942 | $838 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,159 | 1,118 | N/A | N/A | 1,396 |
| Other Non-Current Liabilities | 40 | 0 | 0 | 0 | 0 |
| TOTAL | $1,200 | $1,118 | $0 | $0 | $1,396 |
| Total Liabilities | $3,380 | $3,338 | $2,386 | $1,942 | $2,234 |
| Shareholders' Equity | |||||
| Common Shares | 18,452 | 18,452 | 16,508 | 16,448 | 14,842 |
| Retained earnings | -21,785 | -20,076 | -17,178 | -14,998 | -13,514 |
| Other shareholders' equity | 3 | 3 | 3 | 3 | 78 |
| TOTAL | $1,888 | $3,216 | $2,392 | $4,299 | $3,074 |
| Total Liabilities And Equity | $5,268 | $6,554 | $4,778 | $6,241 | $5,308 |